Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug ...

Retired Oak Ridge, Tennessee, physician notes the downside of a class of drugs − GLP-1s − first approved for treating ...

The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will ...

The Government is considering using drugs to help get obese people back to work - but they can lead to serious health ...

With millions of Americans taking GLP-1 medications for weight loss, the thought of taking one of these medications might ...

The U.K. is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with ...

Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high ...

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...

StudyFinds' Dr. Faith Coleman looks at the common mistakes patients make using GLP-1 agonists like Ozempic and Wegovy.

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...